Sejong Medical, 16.2 Billion KRW Sales Last Year... 9.4% Increase YoY

[Asia Economy Reporter Jang Hyowon] Sejong Medical's performance continues to rise due to the expansion of overseas business.

Sejong Medical, a global healthcare device specialist company, announced on the 19th that its consolidated sales last year reached 16.2 billion KRW, a 9.4% increase compared to the previous year.

Operating profit was 3.8 billion KRW, operating profit margin was 23.2%, net profit was 3.1 billion KRW, and net profit margin was 18.9%, showing improvements in both growth and profitability.

In particular, the increase in sales is attributed to the expansion of overseas business, with the export ratio rising significantly from about 11% in 2018 to about 17% in 2019. Profitability has also steadily improved, with the operating profit margin increasing by 1.7 percentage points compared to the previous year.

A company official stated, “Although these are difficult times, the excellence and competitiveness of our core products, such as disposable 투관침 (Trocar), are being more widely recognized in overseas markets. We will not be complacent and will continue to grow sustainably through expanding our product portfolio and diversifying markets.”

Meanwhile, amid the ongoing market slowdown caused by the coronavirus situation, Sejong Medical has taken proactive steps to enhance shareholder value by deciding on its first-ever dividend payment and acquiring treasury shares.

This content was produced with the assistance of AI translation services.